ICRF GRANT PROGRAMS:

RESEARCH PROFESSORSHIP GRANTS

$550,000 over a 5-year period

Awarded to full-time, senior scientists with established laboratories, who have made outstanding contributions to cancer research.

PROJECT GRANTS

$198,000 over a 3-year period

Awarded to established investigators working on a specific cancer research project.

CLINICAL RESEARCH CAREER DEVELOPMENT AWARDS (CRCDAs)

$148,500 over a 3-year period

Awarded to promising oncologists to conduct clinical research projects early in their career and obtain additional training to become leaders in the field.

RESEARCH CAREER DEVELOPMENT AWARDS (RCDAs)

$148,500 over a 3-year period

Awarded to promising investigators who have recently established their own laboratories and are on their way to becoming outstanding independent investigators.

POST-DOCTORAL FELLOWSHIPS

$99,000 over a 3-year period

Awarded to new MDs and PhDs to apprentice in the laboratories of senior investigators.

ACCELERATION GRANTS

$154,000 over a 2-year period

Awarded to investigators proposing highly innovative approaches that promise to pioneer new ways of thinking about cancer biology and therapeutics.

SPECIAL GRANTS:

COLLABORATIVE FUNDING AWARDS

$495,000 over a 3-year period

Awarded to cancer research projects conducted collaboratively with scientists at a North American research institution and investigators in Israel.

SPECIAL FUNDING INITIATIVES

Minimum of $550,000 over a 3-year period

Awarded to investigators conducting cancer research projects in a particular discipline or cancer type that is undertaken directly in response to a donor-initiated proposal and approved by ICRF’s International Scientific Council.


COLLABORATIVE RESEARCH PARTNERSHIP GRANTS:

ICRF’s international collaboration grants are intended to promote international partnerships for outstanding cancer research in Israel with a collaborator institution/investigator in North America (Canada or the United States).

ICRF-CITY OF HOPE JACKI AND BRUCE BARRON CANCER RESEARCH SCHOLARS’ PROGRAM

A Partnership Between ICRF and City of Hope, generously supported by The Harvey L. Miller Family Foundation
$440,000 over a 2-year period to a team of co-investigators based in the US and Israel

Awarded to foster outstanding collaborative research and promote the exchange of ideas between a team of co-investigators based at City of Hope in the US and at an institution in Israel. The overarching goal of this program is to advance our understanding of cancer and develop life-saving therapies, novel diagnostic approaches and/or prevention strategies by leveraging the knowledge and expertise of scientists in the two countries. The two interrelated components of the program are: 1) Collaborative grants to scientists at City of Hope and in Israel that meet the highest standards of peer-reviewed research; 2) An annual symposium that brings researchers from the US and Israel together to share research discoveries. 

ICRF-CONQUER CANCER (THE ASCO FOUNDATION) CAREER DEVELOPMENT AWARD

A Partnership Between ICRF and Conquer Cancer (The ASCO Foundation)
$200,000 over a 3-year period

Awarded to Israeli clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects.

THE MAX RITVO, ALAN SLIFKA AND DESIREE DATO FUND FOR FUSION-ONCOPROTEIN CANCERS AND METASTASIS

A Partnership Between ICRF, Samuel Waxman Cancer Research Foundation and Alan B. Slifka Foundation
$250,000 over a 2-year period to a team of co-investigators based in the US and Israel

Awarded to support collaborative science conducted by co-investigators in the US and Israel with a focus on (1) Cancers driven by fusion oncoproteins with Ewing’s sarcoma as the prototype; or (2) The roles of epigenetic dysfunction or tumor microenvironment in the development of metastatic cancer. 

ICRF-CANCER RESEARCH INSTITUTE IMMUNOTHERAPY PROMISE GRANTS

A Partnership Between ICRF and Cancer Research Institute
$150,000 over a 2-year period

Awarded to support outstanding basic, pre-clinical or translational research in cancer immunology and immunotherapy conducted by established, mid-level or senior Israeli scientists.

GESHER AWARD FOR ACADEMIC EXCELLENCE IN THE FIELD OF CANCER RESEARCH

A Partnership Between ICRF and the Israel Ministry of Science and Technology (MOST)
Maximum of NIS 600,000 over a 3-year period

Awarded to outstanding Israeli cancer scientists living abroad who wish to return to Israel to develop an independent research program.


NAMED SCIENTIFIC GRANTS:

BRAUSE FAMILY INITIATIVE FOR QUALITY OF LIFE

$275,000 over a 3-year period

Awarded to support established Israeli investigators studying cancer treatment related to pain, side effects and emotional problems experienced by cancer patients in order to maintain the best possible quality of life, with an emphasis on non-opioid solutions.

LEN AND SUSAN MARK INITIATIVE FOR OVARIAN AND UTERINE/MMMT CANCERS GRANT

$315,000 over a 3-year period

Awarded to support established Israeli investigators studying the biology, diagnosis, treatment or prevention of ovarian and/or uterine/MMMT cancers.

BARBARA S. GOODMAN ENDOWED RESEARCH CAREER DEVELOPMENT AWARD (RCDA) FOR PANCREATIC CANCER

$148,000 over a 3-year period

Awarded to support a young Israeli scientist embarking on an independent research career with a particular focus on the biology, diagnosis, treatment, supportive care and/or prevention of pancreatic cancer.

BEVERLEY LIBRACH ABSHEZ INITIATIVE FOR OVARIAN AND FEMALE REPRODUCTIVE SYSTEM CANCERS

$315,000 over a 3-year period

Awarded to support established Israeli investigators studying the diagnosis and/or treatment of ovarian and female reproductive system cancers.


LEARN MORE: